drugset / Trial / NCT03766893

Medication Maintenance Therapy in Community Pharmacy Settings

NCT03766893

Phase 0 Completed 11 enrolled Lifespan University of Rhode Island · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to examine how the pharmacy can better optimize treatment expansion by providing pharmacy-based medication assisted treatment (MAT) for maintenance under a collaborative pharmacy practice agreement.

Timeline

Start
2018-09-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 8 mg Other
Subject Buprenorphine Other / unclassified 24 mg Other
Subject Naloxone Small molecule Other
Subject Naltrexone Small molecule 380 mg Other

Indications